TruCBN™ shows no adverse effects in oral toxicity studies in rats up to 400 mg/kg/day
In 14-day and 90-day repeat-dose oral toxicity studies in Sprague-Dawley rats, TruCBN™ at doses of 100, 200, and 400 mg/kg/day produced no adverse clinical signs, body weight changes, food consumption effects, or clinical pathology changes. The no-observed-adverse-effect-level (NOAEL) was determined to be 400 mg/kg/day.
Evidence Score
Study Evidence
Study 1. Investigation into the oral toxicity profile of TruCBN™.
observationalBauter MR, Hartung V, Dunn C, Jensen RP, McCormick M, Roberts M, DiCarlo-Emery D · Toxicology reports (2026)
Result:
Mechanism Graph
Limitations
- ⚠Animal study, not directly translatable to humans
- ⚠Only tested up to 90 days, long-term effects unknown
- ⚠No sleep quality outcomes measured in this study
Frequently Asked Questions
What is TruCBN™?▼
TruCBN™ is a proprietary high-purity form of cannabinol (CBN) processed to be substantially free of THC.
What is the NOAEL for TruCBN™ in rats?▼
The no-observed-adverse-effect-level (NOAEL) is 400 mg/kg/day based on the 90-day oral toxicity study.
Does this study show that CBN is safe for humans?▼
No, this is an animal study in rats; human safety requires clinical trials.
What are the potential therapeutic uses of CBN mentioned?▼
Potential uses include ocular disease, neuroprotection, antimicrobial, anti-inflammatory, immunosuppressive effects, and sleep quality improvement.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Bauter MR, Hartung V, Dunn C, Jensen RP, McCormick M, Roberts M, DiCarlo-Emery D. "Investigation into the oral toxicity profile of TruCBN™.." Toxicology reports, 2026. PMID: 42383225 DOI: 10.1016/j.toxrep.2026.102296